Oncothyreon: A Failed Drug Autopsy Performed By A Short Seller
12/19/12 - 10:10 AM EST
Fund manager Martin Shkreli offers advice on how to avoid the next Oncothyreon blowup.
Nektar Therapeutics Is a Short
09/12/12 - 07:08 AM EDT
Investor Martin Shkreli believes Nektar's constipation drug is a bust and the stock is a good short.